Jonathan I Lieber - Net Worth and Insider Trading

Jonathan I Lieber Net Worth

The estimated net worth of Jonathan I Lieber is at least $849 dollars as of 2024-04-27. Jonathan I Lieber is the Director of Salarius Pharmaceuticals Inc and owns about 1,500 shares of Salarius Pharmaceuticals Inc (SLRX) stock worth over $743. Jonathan I Lieber is also the CFO of Ocugen Inc and owns about 83 shares of Ocugen Inc (OCGN) stock worth over $106. Details can be seen in Jonathan I Lieber's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan I Lieber has not made any transactions after 2022-06-07 and currently still holds the listed stock(s).

Transaction Summary of Jonathan I Lieber

To

Jonathan I Lieber Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jonathan I Lieber owns 6 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Salarius Pharmaceuticals Inc (SLRX) , and Ocugen Inc (OCGN) among others .

Click here to see the complete history of Jonathan I Lieber’s form 4 insider trades.

Insider Ownership Summary of Jonathan I Lieber

Ticker Comapny Transaction Date Type of Owner
CMPI Checkmate Pharmaceuticals Inc 2020-08-06 See Remarks
SLRX Salarius Pharmaceuticals Inc 2022-06-07 director
OCGN Ocugen Inc 2016-12-02 Chief Financial Officer
RGEN Repligen Corp 2012-09-20 CFO
AGTC Applied Genetic Technologies Corp 2022-08-21 Chief Financial Officer
RLYB Rallybio Corp 2023-02-01 See Remarks

Jonathan I Lieber Latest Holdings Summary

Jonathan I Lieber currently owns a total of 2 stocks. Among these stocks, Jonathan I Lieber owns 1,500 shares of Salarius Pharmaceuticals Inc (SLRX) as of June 7, 2022, with a value of $743 and a weighting of 87.48%. Jonathan I Lieber also owns 83 shares of Ocugen Inc (OCGN) as of December 2, 2016, with a value of $106 and a weighting of 12.52%.

Latest Holdings of Jonathan I Lieber

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SLRX Salarius Pharmaceuticals Inc 2022-06-07 1,500 0.50 743
OCGN Ocugen Inc 2016-12-02 83 1.28 106

Holding Weightings of Jonathan I Lieber


Jonathan I Lieber Form 4 Trading Tracker

According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 1 transactions in Salarius Pharmaceuticals Inc (SLRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Salarius Pharmaceuticals Inc is the acquisition of 1,500 shares on June 7, 2022, which cost Jonathan I Lieber around $7,125.

According to the SEC Form 4 filings, Jonathan I Lieber has made a total of 0 transactions in Ocugen Inc (OCGN) over the past 5 years. The most-recent trade in Ocugen Inc is the acquisition of 83 shares on December 2, 2016, which cost Jonathan I Lieber around $9,750.

Insider Trading History of Jonathan I Lieber

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jonathan I Lieber Trading Performance

GuruFocus tracks the stock performance after each of Jonathan I Lieber's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan I Lieber is -2.46%. GuruFocus also compares Jonathan I Lieber's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan I Lieber within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jonathan I Lieber's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jonathan I Lieber

Average Return

-30.21%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.91 -2.46 -38.51 -30.21 -53.01 -84.64
Relative Return to S&P 500(%) 5.94 -4.62 -41.42 -41.77 -65.26 -97.05

Jonathan I Lieber Ownership Network

Ownership Network List of Jonathan I Lieber

No Data

Ownership Network Relation of Jonathan I Lieber


Jonathan I Lieber Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Jonathan I Lieber is the See Remarks of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

Jonathan I Lieber Mailing Address

Above is the net worth, insider trading, and ownership report for Jonathan I Lieber. You might contact Jonathan I Lieber via mailing address: C/o Histogenics Corporation, 830 Winter Street #3, Waltham Ma 02451.

Discussions on Jonathan I Lieber

No discussions yet.